Editorial: Happy anniversary mifepristone: A decade of promise and challenges

Contraception

Volumn 82, Issue 3, 2010, Pages 219-220

  Jordan, Beth ^a   Shields, Wayne C ^a  

^a Association of Reproductive Health Professionals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE; ABORTIVE AGENT;

CLINICAL PRACTICE; DRUG APPROVAL; DRUG COST; DRUG EFFICACY; DRUG USE; EDITORIAL; HEALTH CARE ACCESS; HEALTH INSURANCE; HEALTH SERVICE; MALPRACTICE; MEDICAL ABORTION; MEDICAL RESEARCH; MEDICOLEGAL ASPECT; POLITICS; PRIMARY HEALTH CARE; RURAL AREA; SAFETY; SURGICAL ABORTION; UNITED STATES; URBAN AREA; VACUUM ASPIRATION; WOMEN'S HEALTH; FEMALE; HUMAN; INDUCED ABORTION; METHODOLOGY;

ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; DRUG APPROVAL; FEMALE; HUMANS; MIFEPRISTONE;

EID: 77955585736     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.05.017     Document Type: Editorial

References (4)

1. Clark W.H., Gold M., Grossman D., and Winikoff B. Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research Contraception 75 2007 245 250
2. Finer L.B., and Wei J. Effect of mifepristone on abortion access in the United States Obstet Gynecol 114 2009 623 630
3. Jones R.K., Zolna M.R., Henshaw S.K., and Finer L.B. Abortion access in the United States: incidence and access to services, 2005 Perspec Sex Reproduc Health 40 2008 6 16
4. Schaff E.A. Mifepristone: ten years later Contraception 81 2010 1 7